Melinda L. Telli

1 ta ish

Stanford University

1. Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

   Elizabeth A. Mittendorf, Hong Zhang, Carlos H. Barrios +17

   MaqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.098778